Search / Trial NCT06224803

Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes

Launched by GLOBAL PREVENTIVE MEDICINE BIOTECH CO., LTD. · Jan 17, 2024

Trial Information

Current as of October 09, 2024

Completed

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age: 20 years old (inclusive) or above, gender is not restricted
  • 2. Diagnosed with type 2 diabetes
  • 3. HbA1c \> 6.5%
  • 4. Coagulation function and platelets are normal
  • 5. Participants voluntarily join this treatment course and sign the informed consent form
  • 6. Not taking other supplements containing blood sugar regulating properties for at least one month
  • Exclusion Criteria:
  • 1. Women who are pregnant, lactating or planning to have children
  • 2. Have factors that significantly affect the absorption of oral drugs, such as inability to swallow, chronic diarrhea, intestinal obstruction, etc.
  • 3. Uncontrolled hypertension (\>180/110 mmHG)
  • 4. People suffering from stroke, elderly dementia, Alzheimer's disease and other brain diseases
  • 5. During this study, the subject used other drugs or treatments that may interfere with this study in addition to blood sugar control medications.
  • 6. GOT\>4 times normal value; GPT\>4 times normal value
  • 7. Creatinine\>4 times the highest normal value
  • 8. Those who are determined by the project administrator to be unfit to participate in this clinical study

About Global Preventive Medicine Biotech Co., Ltd.

Global Preventive Medicine Biotech Co., Ltd. is a pioneering organization dedicated to advancing the field of preventive healthcare through innovative biotechnological solutions. With a focus on developing cutting-edge therapies and interventions, the company aims to enhance patient outcomes and promote wellness on a global scale. Leveraging a team of experienced professionals and state-of-the-art research facilities, Global Preventive Medicine Biotech Co., Ltd. is committed to conducting rigorous clinical trials that adhere to the highest ethical standards, ultimately contributing to the prevention of diseases and the improvement of public health.

Locations

New Taipei, , Taiwan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0